Value-ABP: Value Creation in the Fight Against Antibiotic Resistance: Exploring the roles of Business Actors in International Multisectoral Partnerships

Description

Rapidly increasing anti-microbial resistance (AMR) constitutes a global threat. In combination with a quick decline in antibacterial drug development by pharmaceutical firms, a number of “international multi-sectorial partnerships” (IMSPs) have been founded to address this urgent threat. These partnerships consist of actors from different countries ranging from business and government to academia and civil society. Received research knows little about what influences the success or failure of this new and complex kind of partnership.

Thus, our aim is to understand how differences between actors from different sectors, potential conflicts of interest, and the international dimension to such organizations are related to their value creation processes and outcomes. Specifically, in this project we will map the different roles that business partners play in IMSPs. The project will utilize a multiple-case study, a survey, and a computer agent-based model to analyze cases where “business partner” involvement and their relationships with other types of actors has furthered or hindered the creation of value in IMSPs. The findings will shed much needed light on influential factors that determine the functioning of IMSPs and their success to fight AMR. The scientific output will be a number of publications in peer reviewed journals and will also be communicated to politicians and policymakers within health and industry in Sweden, the EU, and internationally (e.g., WHO and UN).